Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 5.04 AUD 0.4% Market Closed
Updated: Jun 2, 2024

Mayne Pharma Group Ltd
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayne Pharma Group Ltd
Net Issuance of Debt Peer Comparison

Comparables:
NEU
BOT
PBP
C
CU6
ALA

Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Mayne Pharma Group Ltd
ASX:MYX
Net Issuance of Debt
-AU$375.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Net Issuance of Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Net Issuance of Debt
-AU$32.4k
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Net Issuance of Debt
-AU$5.9m
CAGR 3-Years
N/A
CAGR 5-Years
-12%
CAGR 10-Years
6%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Net Issuance of Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arovella Therapeutics Ltd
ASX:ALA
Net Issuance of Debt
-AU$71.8k
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mayne Pharma Group Ltd's Net Issuance of Debt?
Net Issuance of Debt
-375.6m AUD

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Net Issuance of Debt amounts to -375.6m AUD.